BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nelson SA, Sant AJ. Imprinting and Editing of the Human CD4 T Cell Response to Influenza Virus. Front Immunol 2019;10:932. [PMID: 31134060 DOI: 10.3389/fimmu.2019.00932] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Janssens Y, Joye J, Waerlop G, Clement F, Leroux-roels G, Leroux-roels I. The role of cell-mediated immunity against influenza and its implications for vaccine evaluation. Front Immunol 2022;13:959379. [DOI: 10.3389/fimmu.2022.959379] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Torresi J, Edeling MA, Nolan T, Godfrey DI. A Complementary Union of SARS-CoV2 Natural and Vaccine Induced Immune Responses. Front Immunol 2022;13:914167. [DOI: 10.3389/fimmu.2022.914167] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 da Silva MK, Azevedo AAC, Campos DMO, de Souto JT, Fulco UL, Oliveira JIN. Computational vaccinology guided design of multi-epitope subunit vaccine against a neglected arbovirus of the Americas. J Biomol Struct Dyn 2022;:1-18. [PMID: 35285772 DOI: 10.1080/07391102.2022.2050301] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Blanco R, Gómez de Cedrón M, Gámez-Reche L, Martín-Leal A, González-Martín A, Lacalle RA, Ramírez de Molina A, Mañes S. The Chemokine Receptor CCR5 Links Memory CD4+ T Cell Metabolism to T Cell Antigen Receptor Nanoclustering. Front Immunol 2021;12:722320. [PMID: 34950130 DOI: 10.3389/fimmu.2021.722320] [Reference Citation Analysis]
5 Nelson SA, Dileepan T, Rasley A, Jenkins MK, Fischer NO, Sant AJ. Intranasal Nanoparticle Vaccination Elicits a Persistent, Polyfunctional CD4 T Cell Response in the Murine Lung Specific for a Highly Conserved Influenza Virus Antigen That Is Sufficient To Mediate Protection from Influenza Virus Challenge. J Virol 2021;95:e0084121. [PMID: 34076479 DOI: 10.1128/JVI.00841-21] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Oidtman RJ, Arevalo P, Bi Q, McGough L, Russo CJ, Vera Cruz D, Costa Vieira M, Gostic KM. Influenza immune escape under heterogeneous host immune histories. Trends Microbiol 2021:S0966-842X(21)00132-3. [PMID: 34218981 DOI: 10.1016/j.tim.2021.05.009] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Woldemeskel BA, Garliss CC, Blankson JN. SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63. J Clin Invest 2021;131:149335. [PMID: 33822770 DOI: 10.1172/JCI149335] [Cited by in Crossref: 22] [Cited by in F6Publishing: 64] [Article Influence: 22.0] [Reference Citation Analysis]
8 Dykema AG, Zhang B, Woldemeskel BA, Garliss CC, Cheung LS, Choudhury D, Zhang J, Aparicio L, Bom S, Rashid R, Caushi JX, Hsiue EH, Cascino K, Thompson EA, Kwaa AK, Singh D, Thapa S, Ordonez AA, Pekosz A, D'Alessio FR, Powell JD, Yegnasubramanian S, Zhou S, Pardoll DM, Ji H, Cox AL, Blankson JN, Smith KN. Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses. J Clin Invest 2021;131:146922. [PMID: 33830946 DOI: 10.1172/JCI146922] [Cited by in Crossref: 5] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
9 Kerstetter LJ, Buckley S, Bliss CM, Coughlan L. Adenoviral Vectors as Vaccines for Emerging Avian Influenza Viruses. Front Immunol 2020;11:607333. [PMID: 33633727 DOI: 10.3389/fimmu.2020.607333] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
10 Prigge AD, Ma R, Coates BM, Singer BD, Ridge KM. Age-Dependent Differences in T-Cell Responses to Influenza A Virus. Am J Respir Cell Mol Biol 2020;63:415-23. [PMID: 32609537 DOI: 10.1165/rcmb.2020-0169TR] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
11 Sherman AC, Lai L, Bower M, Natrajan MS, Huerta C, Karmali V, Kleinhenz J, Xu Y, Rouphael N, Mulligan MJ. The Effects of Imprinting and Repeated Seasonal Influenza Vaccination on Adaptive Immunity after Influenza Vaccination. Vaccines (Basel) 2020;8:E663. [PMID: 33171854 DOI: 10.3390/vaccines8040663] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Viboud C, Gostic K, Nelson MI, Price GE, Perofsky A, Sun K, Sequeira Trovão N, Cowling BJ, Epstein SL, Spiro DJ. Beyond clinical trials: Evolutionary and epidemiological considerations for development of a universal influenza vaccine. PLoS Pathog 2020;16:e1008583. [PMID: 32970783 DOI: 10.1371/journal.ppat.1008583] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
13 Richards KA, Moritzky S, Shannon I, Fitzgerald T, Yang H, Branche A, Topham DJ, Treanor JJ, Nayak J, Sant AJ. Recombinant HA-based vaccine outperforms split and subunit vaccines in elicitation of influenza-specific CD4 T cells and CD4 T cell-dependent antibody responses in humans. NPJ Vaccines 2020;5:77. [PMID: 32884842 DOI: 10.1038/s41541-020-00227-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
14 Jirru E, Lee S, Harris R, Yang J, Cho SJ, Stout-Delgado H. Impact of Influenza on Pneumococcal Vaccine Effectiveness during Streptococcus pneumoniae Infection in Aged Murine Lung. Vaccines (Basel) 2020;8:E298. [PMID: 32545261 DOI: 10.3390/vaccines8020298] [Reference Citation Analysis]
15 Wagner A, Weinberger B. Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives. Front Immunol 2020;11:717. [PMID: 32391017 DOI: 10.3389/fimmu.2020.00717] [Cited by in Crossref: 20] [Cited by in F6Publishing: 34] [Article Influence: 10.0] [Reference Citation Analysis]